ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Dakota » Medical Oncology

Top Medical Oncology Prescribers in North Dakota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LOUIS GEERAERTS MD

Medical Oncology

2,956

$845K

241
204 are 65+

17%
patients receiving schedule two controlled substances

10%
patients receiving schedule three controlled substances

1%
prescriptions for patients 65+ for potentially dangerous drugs

17%
prescriptions for brand name drugs

$286
Average prescription price

VIJAY RAO MD

Medical Oncology

1,457

$599K

182
163 are 65+

16%
patients receiving schedule two controlled substances

12%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

11%
prescriptions for brand name drugs

$411
Average prescription price

PATANIT WATANABOONYAKHET MD

Medical Oncology

1,152

$195K

145
127 are 65+

15%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

15%
prescriptions for brand name drugs

$169
Average prescription price

PRESTON STEEN MD

Medical Oncology

1,070

$472K

109
92 are 65+

25%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

21%
prescriptions for brand name drugs

$442
Average prescription price

ANU GABA MD

Medical Oncology

861

$223K

113
92 are 65+

13%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

10%
prescriptions for brand name drugs

$259
Average prescription price

MARK GITAU M.D.

Medical Oncology

762

$446K

90
79 are 65+

19%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

20%
prescriptions for brand name drugs

$586
Average prescription price

HOMAYOON SHAHIDI MD

Medical Oncology

476

$201K

90
79 are 65+

12%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

13%
prescriptions for brand name drugs

$422
Average prescription price

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank